Clinical Trial Update: Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the combination of LV5FU2, bevacizumab, and anakinra for metastatic colorectal cancer has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Anakinra (anakinra)
• Bevacizumab (bevacizumab)
• LV5FU2 (leucovorin + fluorouracil (5-FU))

Snippet

Sponsor: Centre Georges Francois Leclerc | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED